KALA Earnings KALA BIO, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.14 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -3.31 | 2026-04-15 | 10-K |
| Q3 2025 | 2025-09-30 | -4.17 | 2025-11-19 | 10-Q |
| Q2 2025 | 2025-06-30 | -3.13 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -70.49 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -10.15 | 2026-04-15 | 10-K |
| Q3 2025 | 2024-09-30 | -8.68 | 2025-11-19 | 10-Q |
| Q2 2025 | 2024-06-30 | -7.32 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -4.20 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -17.35 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -14.36 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -11.15 | 2024-08-06 | 10-Q |
| Q1 2023 | 2023-03-31 | -6.99 | 2023-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -29.48 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | -21.46 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -41.10 | 2023-08-04 | 10-Q |
| Q1 2023 | 2022-03-31 | -22.18 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -108.32 | 2023-03-03 | 10-K |
| Q3 2022 | 2021-09-30 | -73.80 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.06 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.